natgillin/translations-raw huggingface dataset:
Insulinbehovet kan være nedsat under samtidig behandling med lægemidler med hypoglykæmisk aktivitet, f.eks. orale antidiabetika, salicylater (f.eks. acetylsalicylsyre), sulfapræparater, visse antidepressiva (monoaminooxidasehæmmere, selektive serotoningenoptagshæmmere (SSRI)), visse angiotensin konverteringsenzym (ACE)- hæmmere (captopril, enalapril), angiotensin II- receptorblokkere, beta-blokkere, octreotid eller alkohol.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants, (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta- blockers, octreotide or alcohol.
Insulinbehovet kan være reduceret ved nyrefunktionsnedsættelse.
Insulin requirements may be reduced in the presence of renal impairment.
Insulinbehovet kan ændres af interkurrente tilstande såsom sygdom, emotionelle forstyrrelser eller stress.
Insulin requirements may be altered during intercurrent conditions such as illness, emotional disturbances, or stress.
Insulinbehovet kan øges af lægemidler med hyperglykæmisk aktivitet, f.eks. orale antikonceptiva, kortikosteroider eller thyreoideahormon substitutionsterapi, danazol, beta2-stimulerende midler (såsom ritodrin, salbutamol, terbutalin).
Insulin requirements may be increased by substances with hyperglycaemic activity, such as oral contraceptives, corticosteroids, or thyroid replacement therapy, danazol, beta2 stimulants (such as ritodrine, salbutamol, terbutaline).
Insulinblisteren skal skubbes lige ind i blisteråbningen, og så langt ind som muligt.
Slide the insulin blister straight into the blister slot as far as it will go.
Insulindoser og/eller andre doser af hypoglykæmiske lægemidler skal muligvis reduceres hos diabetikere, der får INCRELEX.
Doses of insulin and/or other hypoglycaemic medicinal products may need to be reduced for diabetic subjects using INCRELEX.
Insulindosis (IE/dag) i uge 52b, 3
Insulin dose (IU/day) at week 52b, 3
Insulindosis blev reduceret med 20% hos patienter med baseline HbA1C ≤8,0% for at mindske risikoen for hypoglykæmi.
The insulin dose was reduced by 20% for patients with baseline HbA1c ≤8.0% in order to minimise the risk of hypoglycaemia.
Insulinet bør være klart og farveløst.
It should be clear and colourless.
Insulinet har en hurtigere virkning hvis du injicerer i maveskindet.
The insulin will work more quickly if you inject into the waist (abdomen).
Insulinet skal blandes ved at vippe OptiSet langsomt op og ned mindst 10 gange.
The insulin should be mixed by turning OptiSet slowly up and down at least 10 times.
Insulinet skal resuspenderes umiddelbart før, det trækkes fra hættglasset op i injektionssprøjten.
Immediately before withdrawal from the vial into the injection syringe, the insulin must be resuspended.
Insulinet skal resuspenderes umiddelbart før, det trækkes op fra hætteglasset op i injektionssprøjten.
Immediately before withdrawal from the vial into the injection syringe, the insulin must be resuspended.
Insulinet vil virke hurtigst, hvis det injiceres i maveskindet (abdomen).
The insulin will work more quickly if you inject into the waist (abdomen).
Insulinets udseende skal kontrolleres: insulinsuspensionen skal have et mælkehvidt udseende.
The appearance of the insulin should be checked: the insulin suspension must have an evenly milky-white appearance.
Insulinets udseende skal også kontrolleres: insulinopløsningen skal være klar, farveløs, uden synlige faste partikler og den skal ligne vand.
The appearance of insulin should also be checked: the insulin solution must be clear, colourless, with no solid particles visible, and must have a water-like consistency.
Insulinets udseende skal også kontrolleres: insulinopløsningen skal være klar, farveløs, uden synlige partikler og den skal have en vandig konsistens.
The appearance of insulin should also be checked: the insulin solution must be clear, colourless, with no solid particles visible, and must have a water-like consistency.
Insulinflowet skal kontrolleres før hver injektion for at sikre, at pennen er klar til brug.
The pen must be primed to a stream of insulin before each injection to make sure the pen is ready to dose.
Insulinflowet skal kontrolleres før hver injektion.
Prime every time.
Insulinforvekslinger
Insulin Mix-ups
Insulinfrigivelses- enheden skal udskiftes efter at denne ved et uheld har været udsat for fugtige omgivelser, f.eks. tildampet badeværelse.
The IRU must be changed after accidental exposure to extremely moist conditions, e.g. steamy bathroom.
Insulininfusion (CSII):
Insulin infusion (CSII):
Insulininhalatoren må ikke opbevares i køleskab eller nedfryses.
Do not refrigerate or freeze the insulin inhaler.
Insulininjektion:
Insulin injection:
Insulinopløsningen (Insulin Human Winthrop Rapid) skal være klar, farveløs, uden synlige partikler og skal have en vandlignende konsistens.
The insulin solution (Insulin Human Winthrop Rapid) must be clear, colourless, with no solid particles visible, and must have a water-like consistency.
Insulinopløsningen (Insuman Rapid) skal være klar, farveløs, uden synlige partikler og skal have en vandlignende konsistens.
The insulin solution (Insuman Rapid) must be clear, colourless, with no solid particles visible, and must have a water-like consistency.
Insulinopløsningen skal derefter afgasses i henhold til afgasningsproceduren beskrevet i lægens manual.
The insulin solution must be then degassed according to the degassing procedure described in the Physician’s manual.
Insulinresistens*
Insulin resistance
insulinresistens, dyslipidæmi, akne
insulin resistance, dyslipidemia, acne
Insulinskalaen viser dig hvor meget insulin der cirka er tilbage i din pen.
The insulin scale shows you approximately how much insulin is left in your pen.
Insulinskalaen viser, cirka hvor meget insulin der er tilbage i pennen.
The insulin scale shows you approximately how much insulin is left in your pen.
Insulinsuspensioner bør ikke anvendes, medmindre de er ensartet hvide og uklare efter
Insulin suspensions should not be used if they do not appear uniformly white and cloudy after re- suspension.
Insulinsuspensioner bør ikke anvendes, medmindre de er ensartet hvide og uklare efter opblanding.
Insulin suspensions should not be used if they do not appear uniformly white and cloudy after re- suspension.
Insulinsuspensionerne (Insulin Human Winthrop Basal eller Insulin Human Winthrop blandinger) skal blandes ved at vende SoloStar på hovedet mindst 10 gange, for at opslæmme insulinet igen.
The insulin suspensions (Insulin Human Winthrop Basal or Insulin Human Winthrop mixtures) should be mixed by turning SoloStar up and down at least 10 times to resuspend the insulin.
Insulinsuspensionerne (Insuman Basal eller Insuman blandinger) skal blandes ved at vende SoloStar på hovedet mindst 10 gange, for at opslæmme insulinet igen.
The insulin suspensions (Insuman Basal or Insuman mixtures) should be mixed by turning SoloStar up and down at least 10 times to resuspend the insulin.
Insulinunderlevering mistænkes når:
Insulin under-delivery is suspected when:
Insuman Basal
Comb 15
Insuman Basal 100 IE/ml injektionsvæske, suspension i en fyldt pen
Insuman Basal 100 IU/ml suspension for injection in a pre-filled pen
Insuman Basal 100 IE/ml injektionsvæske, suspension i en fyldt pen
Insuman Basal 100 IU/ml suspension for injection in a pre-filled pen.
Insuman Basal 100 IE/ml injektionsvæske, suspension, i cylinderampul
Insuman Basal 100 IU/ml suspension for injection in a cartridge
Insuman Basal 100 IE/ml injektionsvæske, suspension, i cylinderampul til OptiClik
Insuman Basal 100 IU/ml suspension for injection in a cartridge for OptiClik
Insuman Basal 100 IE/ml injektionsvæske, suspension, i cylinderampul til OptiClik
Insuman Basal 100 IU/ml suspension for injection in a cartridge for OptiClik.
Insuman Basal 100 IE/ml injektionsvæske, suspension, i hætteglas
Insuman Basal 100 IU/ml suspension for injection in a vial
Insuman Basal 100 IE/ml injektionsvæske, suspension, i hætteglas Human insulin.
Insuman Basal 100 IU/ml suspension for injection in a vial Insulin human
Insuman Basal 40 IE/ml injektionsvæske, suspension, i hætteglas
Insuman Basal 40 IU/ml suspension for injection in a vial
Insuman Basal cylinderampuller er ikke beregnet til, at andre insuliner kan iblandes i cylinderampullen.
Insuman Basal cartridges are not designed to allow any other insulin to be mixed in the cartridge.
Insuman Basal cylinderampuller må kun anvendes med følgende penne:
The Insuman Basal cartridges should only be used with the following pens:
Insuman Basal cylinderampuller må kun anvendes med pennene OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar og JuniorSTAR.
The Insuman Basal cartridges are to be used only with the pens: OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
Insuman Basal cylinderampuller til OptiClik, er ikke beregnet til, at andre insuliner kan iblandes i cylinderampullen.
Insuman Basal cartridges for OptiClik are not designed to allow any other insulin to be mixed in the cartridge for OptiClik.
Insuman Basal er en suspension til injektion under huden.
Basal is a fluid (suspension) for injection under the skin.
Insuman Basal er en suspension til injektion under huden.
Insuman Comb 15 is a fluid (suspension) for injection under the skin.
Insuman Basal injektionsvæske, suspension i fyldt pen.
Insuman Basal suspension for injection in a pre-filled pen.
Insuman Basal injiceres subkutant 45 - 60 min. før et måltid.
Insuman Basal is injected subcutaneously 45 to 60 minutes before a meal.
Insuman Basal kan blandes med alle human insulin formuleringer, men ikke med dem designet specifikt til brug i insulinpumper.
Insuman Basal may be mixed with all insulin human formulation, but not with those designed specifically for use in insulin pumps.
Insuman Basal kan blandes med alle human insulin-præparater, dog IKKE med insulin, som er specielt beregnet til brug i insulinpumper.
Insuman Basal may be mixed with all insulin human preparations, EXCEPT those specially designed for use in insulin pumps.
Insuman Basal leveres cylinderampuller med 3 ml suspension (300 IE).
Insuman Basal is supplied in cartridges for OptiClik containing 3 ml suspension (300 IU).
Insuman Basal leveres cylinderampuller som indeholder 3 ml suspension (300 IE).
Insuman Basal is supplied in cartridges containing 3 ml suspension (300 IU).
Insuman Basal leveres i cylinderampuller forseglet i engangspenne, OptiSet.
Insuman Basal comes in cartridges sealed in disposable pen injectors, OptiSet.
Insuman Basal leveres i en cylinderampul fast integreret i en plastikbeholder, som er engangsdelen af insulinpennen OptiClik.
Insuman Basal comes in a cartridge sealed in a plastic container, which is the disposable part of OptiClik, an insulin pen.
Insuman Basal leveres i fyldte penne, OptiSet med 3 ml suspension (300 IE).
Insuman Basal is supplied in pre-filled pens, OptiSet, containing 3 ml suspension (300 IU).
Insuman Basal leveres i fyldte penne, SoloStar, som indeholder 3 ml suspension (300 IE).
Insuman Basal is supplied in pre-filled pens, SoloStar, containing 3 ml suspension (300 IU).
Insuman Basal leveres i hætteglas som indeholder 10 ml suspension (400 IE).
Insuman Basal is supplied in vials containing 10 ml suspension (400 IU).
Insuman Basal leveres i hætteglas, som indeholder 5 ml injektionsvæske (svarende til 500 IE) eller 10 ml injektionsvæske (svarende til 1.000 IE).
Insuman Basal is supplied in vials containing 5 ml of suspension for injection (equivalent to 500 IU) or 10 ml of suspension for injection (equivalent to 1000 IU).
Insuman Basal MÅ IKKE injiceres i en blodåre (vene).
Do NOT inject Insuman Basal into a vein (blood vessel).
Insuman Basal må administreres intravenøst og må ikke bruges i infusionspumper eller eksterne eller implanterede insulinpumper.
Insuman Basal must not be administered intravenously and must not be used in infusion pumps or external or implanted insulin pumps.
Insuman Basal må ikke administreres intravenøst eller bruges i eksterne eller implanterede insulinpumper eller i peristaltiske pumper med silikoneslanger.
Insuman Basal must not be administered intravenously and must not be used in infusion pumps or external or implanted insulin pumps.
Insuman Basal må ikke administreres intravenøst eller bruges i eksterne eller implanterede insulinpumper eller i peristaltiske pumper med silikoneslanger.
Insuman Basal must not be used in external or implanted insulin pumps or in peristaltic pumps with silicone tubing.
Insuman Basal må ikke administreres intravenøst og må ikke bruges i eksterne eller implanterede insulinpumper eller i peristaltiske pumper med silikoneslanger.
Insuman Basal must not be administered intravenously and must not be used in infusion pumps or external or implanted insulin pumps.
Insuman Basal må ikke anvendes, hvis dette ikke kan opnås, f.eks. hvis suspensionen forbliver klar eller klumper, så partikler eller fnug findes i insulinet eller sætter sig på cylinderampullens væg eller bund.
Insuman Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insuman Basal må ikke anvendes, hvis dette ikke kan opnås, f.eks. suspensionen forbliver klar eller klumper, så partikler eller fnug findes i insulinet eller sætter sig på cylinderampullens væg eller bund.
Insuman Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insuman Basal må ikke blandes med andre insuliner eller med insulin-analoger.
Insuman Basal must not be mixed with any other insulin or with insulin analogues.
Insuman Basal må ikke blandes med human insulin formuleringer designet specifikt til brug i insulinpumper.
Insuman Basal must not be mixed with insulin human formulations designed specifically for use in insulin pumps.
Insuman Basal må IKKE blandes med insulin af animalsk oprindelse eller insulin-analoger.
Also, it must NOT be mixed with animal source insulins or insulin analogues.
Insuman Basal må ikke blandes med nogen andre insuliner eller med insulinanaloger.
Insuman Basal must not be mixed with any other insulin or with insulin analogues.
Insuman Basal må ikke komme i direkte berøring med frostboks eller fryseelementer.
Do not put Insuman Basal next to the freezer compartment or a freezer pack.
Insuman Basal OptiSet injiceres under huden 45 til 60 min. før et måltid.
Insuman Basal is injected under the skin 45 to 60 minutes before a meal.
Insuman Basal OptiSet.
Insuman Basal OptiSet
Insuman Basal skal før det sættes ind i pennen opbevares ved stuetemperatur i 1 - 2 timer og herefter rystes op for at kontrollere suspensionen.
Before insertion into the pen, Insuman Basal must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents.
Insuman Basal skal opbevares ved stuetemperatur i 1 - 2 timer før det sættes ind i pennen og herefter resuspenderes for at kontrollere suspensionen.
Before insertion into the pen, Insuman Basal must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents.
Insuman Basal Solostar 100 IE/ml injektionsvæske, suspension i en fyldt pen
Insuman Basal SoloStar 100 IU/ml suspension for injection in a pre-filled pen.
Insuman Basal SoloStar 100 IE/ml injektionsvæske, suspension, i en fyldt pen
Insuman Basal SoloStar 100 IU/ml suspension for injection in a pre-filled pen
Insuman Basal SoloStar er hvid med en farvet doseringsknap.
Insuman SoloStar is white with a colour on the injection button.
Insuman Basal SoloStar injiceres under huden 45 til 60 min. før et måltid.
Insuman Basal is injected under the skin 45 to 60 minutes before a meal.
Insuman Basal, en insulinsuspension med mellemlang virkningstid, som indeholder isophaninsulin
Insuman Basal, an intermediate-acting insulin suspension containing isophane insulin;
Insuman Basal, fyldt pen, OptiSet er ikke beregnet til at andre insuliner kan iblandes i cylinderampullen
Insuman Basal, pre-filled pen, OptiSet, is not designed to allow any other insulin to be mixed in the cartridge.
Insuman blev undersøgt i tre undersøgelser hos 780 patienter med enten type 1-diabetes eller type 2- diabetes.
Insuman has been studied in three trials in 780 patients with either type 1 diabetes or type 2 diabetes.
Insuman Comb 15
Insuman Comb 15 100
Insuman Comb 15
Insuman Comb 15 40
Insuman Comb 15 100 IE/ml injektionsvæske, suspension i en fyldt pen
Insuman Comb 15 100 IU/ml suspension for injection in a pre-filled pen
Insuman Comb 15 100 IE/ml injektionsvæske, suspension i en fyldt pen
Insuman Comb 15 100 IU/ml suspension for injection in a pre-filled pen.
Insuman Comb 15 100 IE/ml injektionsvæske, suspension, i cylinderampul
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge
Insuman Comb 15 100 IE/ml injektionsvæske, suspension, i cylinderampul til OptiClik
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge for OptiClik
Insuman Comb 15 100 IE/ml injektionsvæske, suspension, i cylinderampul til OptiClik
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge for OptiClik.
Insuman Comb 15 100 IE/ml injektionsvæske, suspension, i hætteglas
Insuman Comb 15 100 IU/ml suspension for injection in a vial
Insuman Comb 15 40 IE/ml injektionsvæske, suspension, i hætteglas
Insuman Comb 15 40 IU/ml suspension for injection in a vial
Insuman Comb 15 cylinderampuller er ikke beregnet til, at andre insuliner kan iblandes i cylinderampullen.
Insuman Comb 15 cartridges are not designed to allow any other insulin to be mixed in the cartridge.
Insuman Comb 15 cylinderampuller må kun anvendes med følgende penne:
The Insuman Com 15 cartridges should only be used with the following pens:
Insuman Comb 15 cylinderampuller må kun anvendes med pennene OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar og JuniorSTAR.
The Insuman Comb 15 cartridges are to be used only with the pens: OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
Insuman Comb 15 cylinderampuller til OptiClik er ikke beregnet til, at andre insuliner kan iblandes i cylinderampullen til OptiClik.
Insuman Comb 15 cartridges for OptiClik are not designed to allow any other insulin to be mixed in the cartridge for OptiClik.
Insuman Comb 15 er en bifasisk isophaninsulinsuspension med 15% opløst insulin og 85% krystallinsk protamininsulin.
Insuman Comb 15 is a biphasic isophane insulin suspension consisting of 15% dissolved insulin and 85% crystalline protamine insulin.
Insuman Comb 15 er en insulinopløsning med en gradvist indsættende virkning og lang virkningsvarighed.
Insuman Comb 15 is an insulin preparation with a gradual onset and long duration of action.
Insuman Comb 15 er en opløsning til injiektion under huden.
Insuman Comb 15 is a fluid (suspension) for injection under the skin.
Insuman Comb 15 fyldt pen, OptiSet er ikke beregnet til at andre insuliner kan iblandes i cylinderampullen.
Insuman Comb 15, pre-filled pen, OptiSet, is not designed to allow any other insulin to be mixed in the cartridge.
Insuman Comb 15 i cylinderampuller er udviklet kun til brug i penne af typen OptiClik.
Insuman Comb 15 in cartridges for OptiClik has been developed for use with OptiClik only.
Insuman Comb 15 i cylinderampuller til OptiClik er udviklet udelukkende til anvendelse med OptiClik.
Insuman Comb 15 in cartridges for OptiClik has been developed for use with OptiClik only.
Insuman Comb 15 indeholder
What Insuman Comb 15 contains
Insuman Comb 15 indeholder 40 IE insulin pr. ml.
Insuman Comb 15 contains 40 IU insulin per ml.
Insuman Comb 15 indeholder det aktive stof human insulin, som er fremstillet ved en bioteknologisk proces, og det er identisk med kroppens eget insulin.
Insuman Comb 15 contains the active substance insulin human which is made by a biotechnology process and is identical with the body's own insulin.
Insuman Comb 15 injektionsvæske, suspension i fyldt pen.
Insuman Comb 15 suspension for injection in a pre-filled pen.
Insuman Comb 15 injiceres subkutant 30 - 45 min. før et måltid.
Insuman Comb 15 is injected subcutaneously 30 to 45 minutes before a meal.
Insuman Comb 15 kan blandes med alle human insulin formuleringer, men ikke med dem designet specifikt til anvendelse i insulinpumper.
Insuman Comb 15 may be mixed with all insulin human formulations, but not with those designed specifically for use in insulin pumps.
Insuman Comb 15 kan blandes med alle human insulin-præparater dog IKKE med insulin, som er specielt beregnet til brug i insulinpumper.
Insuman Comb 15 may be mixed with all insulin human preparations, EXCEPT those specially designed for use in insulin pumps.
Insuman Comb 15 kan blandes med alle human insulin-præparater, dog IKKE med insulin, som er specielt beregnet til brug i insulinpumper.
Insuman Comb 15 may be mixed with all insulin human preparations, EXCEPT those specially designed for use in insulin pumps.
Insuman Comb 15 leveres i cylinderampuller forseglet i engangspenne, OptiSet.
Insuman Comb 15 comes in cartridges sealed in disposable pen injectors, OptiSet.
Insuman Comb 15 leveres i cylinderampuller med 3 ml suspension (300 IE).
Insuman Comb 15 is supplied in cartridges for OptiClik containing 3 ml suspension (300 IU).
Insuman Comb 15 leveres i en cylinderampul fast integreret i en plastikbeholder, som er engangsdelen af insulinpennen OptiClik.
Insuman Comb 15 comes in a cartridge sealed in a plastic container, which is the disposable part of OptiClik, an insulin pen.
Insuman Comb 15 leveres i fyldte penne, SoloStar, som indeholder 3 ml suspension (300 IE).
Insuman Comb 15 is supplied in pre-filled pens, SoloStar, containing 3 ml suspension, (300 IU).
Insuman Comb 15 leveres i hætteglas som indeholder 5 ml suspension (500 IE).
Insuman Comb 15 is supplied in vials containing 5 ml suspension (500 IU).
Insuman Comb 15 MÅ IKKE injiceres i en blodåre (vene).
Do NOT inject Insuman Comb 15 into a vein (blood vessel).
Insuman Comb 15 må ikke anvendes hvis dette ikke kan opnås, f.eks. hvis suspensionen forbliver klar eller klumper, så partikler eller fnug findes i insulinet eller sætter sig på cylinderampullens væg eller bund.
Insuman Comb 15 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insuman Comb 15 må ikke anvendes, hvis dette ikke kan opnås, f.eks. hvis suspensionen forbliver klar eller klumper, så partikler eller fnug findes i insulinet eller sætter sig på cylinderampullens væg eller bund.
Insuman Comb 15 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insuman Comb 15 må ikke anvendes, hvis dette ikke kan opnås, hvis f.eks. suspensionen forbliver klar eller klumper, så partikler eller fnug findes i insulinet eller sætter sig på cylinderampullens væg eller bund.
Insuman Comb 15 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insuman Comb 15 må ikke blandes med andre insuliner eller med insulin-analoger.
Insuman Comb 15 must not be mixed with any other insulin or with insulin analogues.
Insuman Comb 15 må ikke blandes med andre lægemidler.
Do not mix insulin with any other medicines.
Insuman Comb 15 må IKKE blandes med insulin af animalsk oprindelse eller insulin-analoger.
Also, it must NOT be mixed with animal source insulins or insulin analogues.
Insuman Comb 15 må ikke blandes med nogen andre insuliner eller med insulinanaloger.
Insuman Comb 15 must not be mixed with any other insulin or with insulin analogues.